These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22711178)

  • 1. Lumican and versican are associated with good outcome in stage II and III colon cancer.
    de Wit M; Belt EJ; Delis-van Diemen PM; Carvalho B; Coupé VM; Stockmann HB; Bril H; Beliën JA; Fijneman RJ; Meijer GA
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S348-59. PubMed ID: 22711178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
    PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of stromal versican expression in human endometrial cancer.
    Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Ann Oncol; 2007 Feb; 18(2):269-74. PubMed ID: 17065588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
    Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
    Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical composition of the human lunotriquetral interosseous ligament.
    Chatuparisute P; Shinohara Y; Kirchhoff C; Fischer F; Milz S
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):318-24. PubMed ID: 22505013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumican is overexpressed in lung adenocarcinoma pleural effusions.
    Cappellesso R; Millioni R; Arrigoni G; Simonato F; Caroccia B; Iori E; Guzzardo V; Ventura L; Tessari P; Fassina A
    PLoS One; 2015; 10(5):e0126458. PubMed ID: 25961303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data.
    Aydin SG; Olmez OF; Selvi O; Geredeli C; Ozden F; Bilici A; Acikgoz O; Karci E; Kutlu Y; Hamdard J; Aydin A
    J Gastrointest Cancer; 2024 Mar; 55(1):227-236. PubMed ID: 37347353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence.
    Belt EJ; Fijneman RJ; van den Berg EG; Bril H; Delis-van Diemen PM; Tijssen M; van Essen HF; de Lange-de Klerk ES; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Eur J Cancer; 2011 Aug; 47(12):1837-45. PubMed ID: 21621406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.
    Kim NS; Lee HH; Jung CK; Jeon HM
    Anticancer Res; 2014 Oct; 34(10):5613-9. PubMed ID: 25275064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy.
    Turksma AW; Coupé VM; Shamier MC; Lam KL; de Weger VA; Belien JA; van den Eertwegh AJ; Meijer GA; Meijer CJ; Hooijberg E
    Clin Cancer Res; 2016 Jan; 22(2):346-56. PubMed ID: 26420855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CXCR4 and CD133 co-expression on the prognosis of patients with stage II~III colon cancer.
    Li XF; Guo XG; Yang YY; Liu AY
    Asian Pac J Cancer Prev; 2015; 16(3):1073-6. PubMed ID: 25735334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis.
    Voutilainen K; Anttila M; Sillanpää S; Tammi R; Tammi M; Saarikoski S; Kosma VM
    Int J Cancer; 2003 Nov; 107(3):359-64. PubMed ID: 14506734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.